Physician

Orion Maurice Howard, M.D.

According to 2025 Medicare claims, Orion Howard, M.D. (NPI: 1649205436) practices medical oncology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (NPI: 1295787919; TIN: 043194547) and primary practice location at 01061-5001. Howard is affiliated with the UMASS Memorial Accountable Care Organization, INC. (ACO ID: A2598) and Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Howard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 378 traditional Medicare patients, billed 1,900 HCPCS/CPT codes, and received $117,659 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 644 prescription claims across 135 beneficiaries totaling $4,843,804 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 30 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $938,940 to $4,843,804. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,781 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	389	1,517	$92,703
2016	370	1,561	$96,731
2017	407	989	$56,675
2018	173	574	$38,704
2019	175	482	$31,649
2020	299	1,073	$70,152
2021	342	1,108	$89,182
2022	400	1,313	$104,815
2023	372	1,170	$89,514
2024	378	1,900	$117,659

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	105	608	$938,940
2016	121	772	$1,370,271
2017	91	480	$943,792
2018	61	204	$628,903
2019	42	154	$516,505
2020	70	207	$662,084
2021	79	303	$1,817,711
2022	152	628	$3,399,327
2023	146	655	$4,029,356
2024	135	644	$4,843,804

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	129	$38,063
2016	N/R	40	$25,471
2017	N/R	55	$33,422
2018	N/R	N/R	N/R
2019	N/R	11	$467
2020	N/R	N/R	N/R
2021	N/R	27	$2,253
2022	N/R	37	$1,262
2023	N/R	11	$698
2024	N/R	30	$816

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	71	144	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	317	797	$92
99443	Telephone medical discussion with physician, 21-30 minutes	49	50	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	40	52	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	319	746	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	60	1,800	$815,664
Xtandi	Enzalutamide	44	1,300	$546,123
Lenalidomide	Lenalidomide	46	1,288	$541,809
Revlimid	Lenalidomide	29	812	$533,491
Lorbrena	Lorlatinib	22	660	$454,146

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$552
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$263

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Orion Maurice Howard, M.D.?

Tedicare shows public-source Medicare data for Orion Maurice Howard, M.D. (NPI 1649205436), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Orion Maurice Howard, M.D. have ACO affiliation data?

Orion Maurice Howard, M.D. is shown with ACO affiliation data for UMASS Memorial Accountable Care Organization, INC. (MSSP, ACO ID A2598) and Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Orion Maurice Howard, M.D.?

Orion Maurice Howard, M.D. is linked to MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (billing NPI 1295787919) in the available physician profile data.

Does Orion Maurice Howard, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.